. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: J Immunol. 2013 Oct 25;191(11):10.4049/jimmunol.1301604. doi: 10.4049/jimmunol.1301604

Table 1.

Decrease in gene expression and ISIS^a of a2V in uterus and placenta correlated with preterm labor

Treatment	Tissues	Relative Gene expression of a2V	Protein level of a2V	Preterm delivery (%)
Control	Uterus	28.40±3.7	10.92±0.4	0/5 (0)
	Placenta	26.08±1.6	10.70±0.3
	Fetal Membrane	12.15±2.1	-
	Fetus	28.33±2.44	-
PGN+poly (I:C)	Uterus	12.20±1.4*	6.62±0.5^**	11/15 (73)
	Placenta	16.8±2.2*	7.7±0.4^**
	Fetal Membrane	5.89+1.45*	-
	Fetus	28±2.63	-

Immunostaining index score (ISIS) = Stained area score (SAS) X Immunostaining intensity score (IIS)

^**

Significant difference vs. respective control; p≤0.01.